arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

PALVELLA THERAPEUTICS, INC.

PVLA

$157.51 ▲ +2.86 (+1.85%) at close

14 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

PALVELLA THERAPEUTICS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.8B

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -137.9% ↘

FCF / Share $-2.22 ↗

Trailing P/E —

Price / Book 69.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$42.81M

↑ +65.3% —

Net Income Profit after all expenses

$-41.72M

↓ -139.3% —

Operating Margin Operating profit as % of sales

-69.5%

↑ +58.6% —

FCF / Share Free cash flow per share

$-2.22

↑ +54.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Revenue Growth YoY (%)	—	—	65.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+716%)	-17.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-319%)	7.1% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-11%)	-36.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-558%)	59.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+638%)	15.1% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+89%)	333.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4069%)	98.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1136%)	-45.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-667%)	-56.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-810%)	—	—
EPS Growth YoY (%)	52.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2800.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	40.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	36.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-4.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-139.3% Weak ↓ Weak Declining Year-over-year change in net income	29.0% Excellent ↑ Excellent Improving Year-over-year change in net income	26.2% Excellent ↑ Excellent Improving Year-over-year change in net income	27.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-22.9% Weak ↑ Weak Improving Year-over-year change in net income	-46.2% Weak ↓ Weak Declining Year-over-year change in net income	4.8% Caution ↑ Caution Improving Year-over-year change in net income	-51.6% Weak ↓ Weak Declining Year-over-year change in net income	22.6% Good ↑ Good Improving Year-over-year change in net income	-62.2% Weak Weak Year-over-year change in net income	-42.7% Weak Weak Year-over-year change in net income	N/M	—	—
FCF Growth YoY (%)	54.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-712.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	27.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-516.3% Weak Weak Year-over-year change in free cash flow	85.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	13.4% Good ↑ Good Improving Compound annual revenue growth over 3 years	-17.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	2.6% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	5.1% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	99.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	114.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	67.6% Excellent Excellent Compound annual revenue growth over 3 years	-22.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	—	8.0% Good ↓ Good Declining Compound annual revenue growth over 5 years	0.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	40.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	58.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	53.9% Excellent Excellent Compound annual revenue growth over 5 years	18.6% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Operating Margin (%) (%)	—	—	-69.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-563%)	-167.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1219%)	-165.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1200%)	-115.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-871%)	-58.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-491%)	-105.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-806%)	-57.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-485%)	-390.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2702%)	-466.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3211%)	-134.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-994%)	4.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-70%)	—
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	—	-57.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-578%)	-128.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1171%)	-145.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1313%)	-127.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1158%)	-55.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-559%)	-91.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-866%)	-69.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-682%)	-391.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3359%)	-479.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4096%)	-183.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1630%)	0.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-96%)	—
FCF Margin (%) (%)	—	—	-126.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-235.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-27.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-165.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-118.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-9.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	189.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.20x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.83x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	2.16x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-2.71x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Return on Invested Capital (%)	-137.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-111.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-155.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-102.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-109.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-76.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-135.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-90.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	74.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-64.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-76.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	7.6% Fair Fair Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-149.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1094%)	-27.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-286%)	-91.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-711%)	-119.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-894%)	-90.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-701%)	-120.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-900%)	-49.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-431%)	-67.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-547%)	-153.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1121%)	-90.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-703%)	-45.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-54.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-465%)	11.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-25%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Interest Coverage (x)	—	-32.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	-2.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	1.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-57.98M	$-83.60M	$-17.40M	$-38.63M	$-117.76M	$-70.44M	$-62.26M	$-74.87M	$-37.88M	$-29.36M	$-29.35M	$-18.47M	$-3.69M	$0.00

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Revenue per Share (USD)	—	—	$0.48	$0.35	$0.49	$0.54	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-3.71	$-7.83	$-0.27	$-0.45	$-0.71	$-0.68	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-2.22	$-4.87	$-0.60	$-0.82	$-0.13	$-0.89	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.26	$5.69	$0.27	$0.37	$0.70	$0.55	$0.93	$0.74	$0.26	$0.59	$0.78	$1.30	$0.05	—
Tangible Book Value per Share (USD)	$2.26	$5.69	$0.27	$0.37	$0.70	$0.55	$0.93	$0.74	$0.26	$0.59	$0.78	$1.30	$0.05	—
Basic Weighted Avg Shares (shares)	11.25M	2.23M	90.06M	74.17M	64.55M	54.48M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Working Capital (USD)	$47.64M	$76.20M	$26.76M	$36.84M	$77.06M	$53.58M	$88.01M	$87.31M	$44.02M	$24.29M	$28.86M	$16.26M	$3.05M	—
Total Equity (USD)	$27.98M	$62.61M	$26.76M	$27.93M	$50.76M	$31.03M	$51.35M	$39.94M	$11.52M	$25.23M	$31.13M	$18.01M	$585.01K	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Jun 30, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	$42.81M	$25.90M	$31.42M	$29.32M	$46.28M	$29.10M	$25.27M	$5.83M	$2.93M	$5.37M	$12.43M	—
Depreciation Expense (USD)	—	—	$1.90M	$2.77M	$2.46M	$2.10M	$600.00K	$570.00K	$369.00K	$361.38K	$307.91K	$366.98K	$384.68K	—
Net Income, GAAP (USD)	$-41.72M	$-17.43M	$-24.54M	$-33.28M	$-45.74M	$-37.23M	$-25.47M	$-26.75M	$-17.65M	$-22.80M	$-14.06M	$-9.85M	$66.20K	—
Operating Cash Flow (USD)	$-25.01M	$-10.84M	$-53.82M	$-59.93M	$-7.66M	$-45.90M	$-52.47M	$-1.07M	$49.75M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters

PALVELLA THERAPEUTICS, INC.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PVLA with peers